Edgewise Therapeutics (EWTX) total liabilities

Total liabilities · fiscal 2025
$30.35M

Edgewise Therapeutics (EWTX) had total liabilities of $30.35M at the end of fiscal 2025 (December 31, 2025). That is 9.9% higher than the $27.60M of fiscal 2024. Figures as of 19 Nov 2026, 02:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$30.35M
Change on fiscal 2024
+9.9%
Growth, 5 years
+47.5% a year
Highest on record
$30.35Mfiscal 2025
Lowest on record
$4.34Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Edgewise Therapeutics total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 47.5% a year. Across the 6 fiscal years on record (2020–2025), the highest was $30.35M in fiscal 2025 and the lowest $4.34M in fiscal 2020.

History · 6 fiscal years

Total liabilities by fiscal year

Edgewise Therapeutics total liabilities, year by year

Edgewise Therapeutics (EWTX) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$30.35M 9.9% up
2024$27.60M 30.2% up
2023$21.21M 4.0% up
2022$20.39M 87.9% up
2021$10.85M 149.9% up
2020$4.34M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Edgewise Therapeutics and comparable companies
CompanyTotal liabilitiesFiscal year
Concentra Group Holdings Parent CON$2.44B2025
Merit Medical Systems MMSI$1.10B2025
Edgewise Therapeutics EWTX$30.35M2025
LivaNova LIVN$1.41B2025
Ionis Pharmaceuticals IONS$3.03B2025
Dianthus Therapeutics DNTH$37.52M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on EWTX

Edgewise Therapeutics, figure by figure

Edgewise Therapeutics (EWTX) overview: price, valuation and scorecardAll health care companies by market value

Edgewise Therapeutics total liabilities: questions and answers

How large are Edgewise Therapeutics's total liabilities?

Edgewise Therapeutics (EWTX) had total liabilities of $30.35M at the end of fiscal 2025 (December 31, 2025). That is 9.9% higher than the $27.60M of fiscal 2024.

What is the growth rate of Edgewise Therapeutics's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 47.5% a year.

What are the highest and lowest total liabilities figures on record for Edgewise Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $30.35M in fiscal 2025 and the lowest $4.34M in fiscal 2020.

How is Edgewise Therapeutics's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Edgewise Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Edgewise Therapeutics (EWTX) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/EWTX/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.